Zweig-DiMenna Associates’s Chemours CC Stock Holding History

Zweig-DiMenna Associates’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-4,200	Closed	-$213K	–	135
2017 Q3	$213K	Buy	+4,200	New	+$198K	0.02%	167

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Zweig-DiMenna Associates's CC Position: Q4 2017 in Review

Zweig-DiMenna Associates sold out of Chemours (CC) in Q4 2017, closing a stake of 4,200 shares — an estimated $213K sold.

Zweig-DiMenna Associates first reported a position in CC in Q3 2017 and held it in 1 quarter. The position peaked at $213K in Q3 2017. 537 funds tracked by Wall St. Rank hold CC as of Q4 2017.

Zweig-DiMenna Associates reported no remaining Chemours position as of Q4 2017 after selling out during the quarter.
Zweig-DiMenna Associates sold 4,200 Chemours shares in Q4 2017, an estimated $213K.
Zweig-DiMenna Associates first reported a position in Chemours in Q3 2017 and held it in 1 quarter.
Zweig-DiMenna Associates's Chemours position peaked at $213K in Q3 2017.
537 funds tracked by Wall St. Rank held Chemours as of Q4 2017.

Based on Zweig-DiMenna Associates's 13F filing for Q4 2017, filed 12 Feb 2018.